Matthieu Le Gallo

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Binding Protein

Top Venues

The FEBS journal

Molecular cancer research : MCR

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Diana Pelizzari-Raymundo, Victoria Maltret, Manon Nivet, Raphael Pineau, Alexandra Papaioannou, Xingchen Zhou, Flavie Caradec, Sophie Martin, Matthieu Le Gallo, Tony Avril, Éric Chevet, Élodie Lafont
IRE1 RNase controls CD95-mediated cell death. EMBO reports 25 (4) (2024)
Diana Pelizzari-Raymundo, Victoria Maltret, Manon Nivet, Raphael Pineau, Alexandra Papaioannou, Xingchen Zhou, Flavie Caradec, Sophie Martin, Matthieu Le Gallo, Tony Avril, Éric Chevet, Élodie Lafont
IRE1 RNase controls CD95-mediated cell death. EMBO reports 25 (4) (2024)
Diana Pelizzari-Raymundo, Victoria Maltret, Manon Nivet, Raphael Pineau, Alexandra Papaioannou, Xingchen Zhou, Flavie Caradec, Sophie Martin, Matthieu Le Gallo, Tony Avril, Éric Chevet, Élodie Lafont
IRE1 RNase controls CD95-mediated cell death. EMBO reports (2024)
Diana Pelizzari-Raymundo, Victoria Maltret, Manon Nivet, Raphael Pineau, Alexandra Papaioannou, Xingchen Zhou, Flavie Caradec, Sophie Martin, Matthieu Le Gallo, Tony Avril, Éric Chevet, Élodie Lafont
IRE1 RNase controls CD95-mediated cell death. EMBO reports 25 (4) (2024)
Diana Pelizzari-Raymundo, Victoria Maltret, Manon Nivet, Raphael Pineau, Alexandra Papaioannou, Xingchen Zhou, Flavie Caradec, Sophie Martin, Matthieu Le Gallo, Tony Avril, Éric Chevet, Élodie Lafont
IRE1 RNase controls CD95-mediated cell death. EMBO reports 25 (4) (2024)
Diana Pelizzari-Raymundo, Victoria Maltret, Manon Nivet, Raphael Pineau, Alexandra Papaioannou, Xingchen Zhou, Flavie Caradec, Sophie Martin, Matthieu Le Gallo, Tony Avril, Éric Chevet, Élodie Lafont
IRE1 RNase controls CD95-mediated cell death. EMBO reports 25 (4) (2024)
Vesna Risso, Mélissa Thomas, Blandine Guével, Regis Lavigne, Emmanuelle Com, Sophie Martin, Manon Nivet, Charles Pineau, Luc Negroni, Élodie Lafont, Éric Chevet, Leif A Eriksson, Matthieu Le Gallo
Metalloprotease-mediated cleavage of CD95 Ligand. The FEBS journal (2023)
Vesna Risso, Mélissa Thomas, Blandine Guével, Regis Lavigne, Emmanuelle Com, Sophie Martin, Manon Nivet, Charles Pineau, Luc Negroni, Élodie Lafont, Éric Chevet, Leif A Eriksson, Matthieu Le Gallo
Metalloprotease-mediated cleavage of CD95 ligand. The FEBS journal (2023)
Vesna Risso, Élodie Lafont, Matthieu Le Gallo
Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases. Cell death & disease 13 (3) (2022)
Molly M Wilson, Céline Callens, Matthieu Le Gallo, Svetlana Mironov, Qiong Ding, Amandine Salamagnon, Tony E Chavarria, Roselyne Viel, Abena D Peasah, Arjun Bhutkar, Sophie Martin, Florence Godey, Patrick Tas, Hong Soon Kang, Philippe P Juin, Anton M Jetten, Jane E Visvader, Robert A Weinberg, Massimo Attanasio, Claude Prigent, Jacqueline A Lees, Vincent J Guen
An EMT-primary cilium-GLIS2 signaling axis regulates mammogenesis and claudin-low breast tumorigenesis. Science advances 7 (44) (2021)
Thibault De La Motte Rouge, Julien Corné, Aurélie Cauchois, Marie Le Boulch, Clotilde Poupon, Sébastien Henno, Nathalie Rioux-Leclercq, Estelle Le Pabic, Bruno Laviolle, Véronique Catros, Jean Levêque, Alain Fautrel, Matthieu Le Gallo, Patrick Legembre, Vincent Lavoué
Serum CD95L Level Correlates with Tumor Immune Infiltration and Is a Positive Prognostic Marker for Advanced High-Grade Serous Ovarian Cancer. Molecular cancer research : MCR 17 (12) (2019)